We are incredibly grateful for the generosity of our sponsors and supporters of The Rare Disease Showcase Series 2023.
Platinum Series Sponsor
LifeArc is a self-funded, not-for-profit medical research organisation. We take science ideas out of the lab and help turn them into medical breakthroughs that can be life-changing for patients. We have been doing this for more than 25 years and our work has contributed to five licensed medicines, including cancer drug pembrolizumab, and a diagnostic for antibiotic resistance.
Our teams are experts in drug and diagnostics discovery, technology transfer, and intellectual property. LifeArc is committed to spending £1.3 billion by 2030 in areas of high unmet medical need.
Find out more about our work on www.lifearc.org or LinkedIn or Twitter.
Gold Sponsors – London Showcase
The National Institute for Health and Care Research (NIHR) BioResource is a national recallable health resource with a mission to help scientific discoveries move more quickly from the lab to the patient.
Since 2007, we have recruited more than 250,000 volunteers who have participated in more than 300 health research studies in academia, the NHS and industry. There are currently 18 local BioResource Centres across England, each connected to the corresponding local Biomedical Resource Centre, also an NIHR-supported infrastructure.
BioResource volunteers provide samples and access to health records and questionnaires to help researchers better understand how genetics and environment impact health. The Rare Disease BioResource volunteers contribute to research in more than 60 disease areas, including immunology, neuroscience, haematology, rheumatology, cardiovascular disease, and many more.
Programmes such as the RNA phenotyping project and the recently launched DNA, Children + Young People’s Health Resource (D-CYPHR) children ages 0-15 aim to better understand how and why rare diseases occur and close the knowledge gap when it comes to under-represented research areas.
Together with health researchers, we are committed to leading research that will benefit everyone.
Pleco Therapeutics BV is a private Dutch biopharmaceutical company, established in 2018 to develop a portfolio of therapies in the field of cancer medicine. Building on independent proof of the concept in humans, we are progressing a portfolio of novel first-in-class Plecoid™ therapies that remove the burden of toxic metals within the cancer
Currently in pre-clinical development our initial programs focus is on treatments for Acute Myeloid Leukaemia (AML) and Small Cell Lung Cancer (SCLC).
Silver Sponsor – London Showcase
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.
There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment.
By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.
Bronze Series Sponsors
Our sponsors and supporters have provided financial support for this event. This event has been organised by Beacon and neither our sponsors nor supporters have determined the content or organisation. All funds received by pharmaceutical companies have been used in accordance with the ABPI code.